Clinical trial · Observational
A Study of Survivorship Service Capacities Among Health Care Agencies in New York City
NCT00578162CI-TRIAL-00006027completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To describe the range of services available to cancer survivors in the NYC area. To determine organizations' need for assistance to enhance services for survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| All Cancers | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| we will screen potential agencies using our CALL SCRIPT and our AGENCY SCREENER | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Data about participating agencies will be collected by electronic survey. Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory.
- interventionNames
- Behavioral: we will screen potential agencies using our CALL SCRIPT and our AGENCY SCREENER
Primary outcomes (1)
- measure
- To determine agencies' need for assistance to enhance services for survivors.
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria:
* To be eligible to participate in the study, an agency must:
1. Be a current provider of either:
* General health services (GHS), such as primary care, health education and wellness, mental health services, home health care, palliative care, or cancer screening and diagnosis;
* Cancer-specific medical treatments (CMT), such as cancer surgery, radiation, chemotherapy, hormonal therapy; experimental therapies; cancer pain and symptom management; rehabilitation services; post-treatment monitoring and surveillance; or prophylactic treatments, such as chemoprevention; or
* Any type of specialized 'post-cancer' or 'after-cancer' medical care or support services (SMC) (i.e., psychotherapeutic, relationship and family, psycho-educational,wellness and quality of life)
2. Be located within the five boroughs of New York City
3. Have been serving cancer patients for 12 months or longer, and
4. Be willing and able to identify an English-speaking representative, 21 years of age or older as its designated key informant.
Exclusion Criteria:
* We will limit this study to provider agencies such as hospitals, diagnostic centers, clinics, health and human service agencies, and grassroots community organizations and public service settings that offer programs for cancer survivors. Independent practitioners or private practice settings will not be surveyed. Our survey questions are intended for major health services organizations and are not appropriate for private practices settings.
We will use our screening questionnaire to determine where or not a given agency should be included or excluded from the study AGENCY SCREENER.References
Publications (0)
Data not yet available
No reference posted for this study.